LISA HANNA: Open Payments
NPI 1568763043 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,816 in 70 payments from 23 companies in 2025. Trend: 2023 $810 · 2024 $1,624 · 2025 $1,816
Food & beverage: $1,816
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $255 |
| Daiichi Sankyo Inc. | 8 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $148 |
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| Novartis Pharmaceuticals Corporation | 5 | $136 |
| Janssen Biotech, Inc. | 4 | $120 |
| Exelixis Inc. | 3 | $106 |
| ABBVIE INC. | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
Products named: Enhertu, KEYTRUDA, KISQALI, FRUZAQLA, CABOMETYX, Nubeqa, RYBREVANT, BRUKINSA.
Industry payments across CA — which companies pay providers there.
